Israel CINV Existing and Pipeline Drugs Market (2025-2031) | Industry, Trends, Growth, Forecast, Share, Companies, Competitive Landscape, Size & Revenue, Analysis, Segmentation, Outlook, Value

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Israel Country Macro Economic Indicators

3.2 Israel CINV Existing and Pipeline Drugs Market Revenues & Volume, 2021 & 2031F

3.3 Israel CINV Existing and Pipeline Drugs Market - Industry Life Cycle

3.4 Israel CINV Existing and Pipeline Drugs Market - Porter's Five Forces

3.5 Israel CINV Existing and Pipeline Drugs Market Revenues & Volume Share, By Major Drug, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer in Israel

4.2.2 Growing awareness and diagnosis of chemotherapy-induced nausea and vomiting (CINV)

4.2.3 Advancements in oncology research leading to the development of new and more effective CINV drugs

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for drug approval in Israel

4.3.2 High cost associated with the development and commercialization of CINV drugs

4.3.3 Competition from existing therapeutic options for managing CINV

6.1 Israel CINV Existing and Pipeline Drugs Market, By Major Drug

6.1.1 Overview and Analysis

6.1.2 Israel CINV Existing and Pipeline Drugs Market Revenues & Volume, By Major Drug, 2021- 2031F

6.1.3 Israel CINV Existing and Pipeline Drugs Market Revenues & Volume, By Aloxi (Palonosetron), 2021- 2031F

6.1.4 Israel CINV Existing and Pipeline Drugs Market Revenues & Volume, By Zofran Generic (Ondansetron), 2021- 2031F

6.1.5 Israel CINV Existing and Pipeline Drugs Market Revenues & Volume, By Kytril Generic (Granisetron), 2021- 2031F

6.1.6 Israel CINV Existing and Pipeline Drugs Market Revenues & Volume, By Emend (Aprepitant), 2021- 2031F

6.1.7 Israel CINV Existing and Pipeline Drugs Market Revenues & Volume, By Akynzeo (Netupitant-Palonosetron), 2021- 2031F

6.1.8 Israel CINV Existing and Pipeline Drugs Market Revenues & Volume, By SUSTOL (Extended Release Granisetron Injection), 2021- 2031F

7.1 Israel CINV Existing and Pipeline Drugs Market Export to Major Countries

7.2 Israel CINV Existing and Pipeline Drugs Market Imports from Major Countries

8.1 Number of clinical trials for CINV drugs conducted in Israel

8.2 Adoption rate of new CINV drugs in the Israeli market

8.3 Patient satisfaction and compliance rates with CINV treatment regimens

9.1 Israel CINV Existing and Pipeline Drugs Market Opportunity Assessment, By Major Drug, 2021 & 2031F

10.1 Israel CINV Existing and Pipeline Drugs Market Revenue Share, By Companies, 2024

10.2 Israel CINV Existing and Pipeline Drugs Market Competitive Benchmarking, By Operating and Technical Parameters